3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
drugdeliverybusiness11d
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends
Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...
pharmaphorum3d
A milestone in insulin automation, Medtronic's MiniMed 670G hits the market
Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...
GlobalData on MSN5mon
Abbott and Medtronic partner to integrate CGM system with insulin devices
The platform, which includes the new form factor CGM and the Simplera Sync sensor, is designed for integration with Medtronic ...
Medical Design and Outsourcing24y
This Medtronic innovation ‘could be the biggest thing we ever do,’ CEO Geoff Martha says
Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...
Healio6d
Although superior to other insulin therapies, hybrid closed-loop systems differ in efficacy
Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...
Truist Financial Sticks to Its Hold Rating for Medtronic (MDT)
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...